awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28073826-E067ADE4-7FB8-462D-92D2-95073E88AEDD
Q28073826-E067ADE4-7FB8-462D-92D2-95073E88AEDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28073826-E067ADE4-7FB8-462D-92D2-95073E88AEDD
Unveiling changes in the landscape of patient populations in cancer early drug development
P2860
Q28073826-E067ADE4-7FB8-462D-92D2-95073E88AEDD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28073826-E067ADE4-7FB8-462D-92D2-95073E88AEDD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8235868bc2dae6c91899dfb7c7ab570569f3a5ce
P2860
Prospective multicentric randomized phase III study of imatinib in patients with advanced gastrointestinal stromal tumors comparing interruption versus continuation of treatment beyond 1 year: the French Sarcoma Group.